Steven Cohen acquired 1.27 Million Cabaletta Bio shares worth $1.51 Million. That's 0.00% of their equity portfolio (717th largest holding). The investor owns 2.49% of the outstanding Cabaletta Bio stock. The first Cabaletta Bio trade was made in Q3 2021. Since then Steven Cohen bought shares five more times and sold shares on five occasions. The investor's estimated purchase price is $6.12 Million, resulting in a loss of 75%.